CIK: 1185468 - Address: C/o Enzon Pharmaceuticals, Inc., 20 Kingsbridge Road, Piscataway, NJ 08854
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret11241657798317168
P%wins100100100100100100100

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

7/6/10 19:00
7/2/10
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagSalisbury Robert CNJDM.d00.00103750D4132-2-13-6-7-4237817-2
7/6/09 17:00
7/2/09
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagSalisbury Robert CNJDM.dm00.00341239D-1734269-42-1131053432
11/14/08 18:19
11/13/08
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagSalisbury Robert CNJDP.a323.222104035D-55-62-59-61-44-26-27-6213547680168
11/14/08 15:10
11/13/08
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagSalisbury Robert CNJDP323.222104035D-55-62-59-61-44-26-27-6619608286174
7/3/08 16:01
7/1/08
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagSalisbury Robert CNJDM.dm00.00362825D-2-7-21-22-17-8-51-1-214-3-225
7/3/07 15:59
7/1/07
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagSalisbury Robert CNJDM.dm00.0062349D205-6-2-7-7-6-21-2-91421-9
7/5/06 13:49
7/1/06
ENZNEnzon Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagSalisbury Robert CNJDM.d00.0071227D-40142-64133016894
1/5/04 12:16
1/2/04
VRAViragen IncDEHealthBioPrdBiological Products, (No DiagSalisbury Robert CFLDOP,CEOM.d190.11000175583205D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact